NeuroSigma
Los Angeles, US · 1 known investors
NeuroSigma is a bioelectronic medical device company that makes non-invasive external trigeminal-nerve stimulation systems to treat chronic neurological and neuropsychiatric disorders. Its Monarch eTNS System is an FDA-cleared, prescription home-use device for treating pediatric ADHD in children ages 7 to 12, with additional programs targeting conditions such as autism spectrum disorder, epilepsy, and depression.</parameter> <parameter name="founders">[]
Digital HealthHealthtechMedical Devices
Founders & leadership
LE
Leon EkchianExecutive Officer, Director
KC
Kirk CalhounDirector
LM
Lodwrick M. CookDirector
JH
James HindmanDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$11.7MraisedAug 2016 · 9 investors · Other Health CareRule 506(b)
▶$11.7MraisedAug 2016 · 9 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Leon EkchianExecutive Officer, Director
- Kirk CalhounDirector
- Lodwrick M. CookDirector
- James HindmanDirector
- Amount sold
- $11.7M
- First sale
- Aug 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.